Cite

HARVARD Citation

    Butt, J. et al. (2022). Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation. 146 (16), pp. 1210-1224. [Online]. 
  
Back to record